InsiderClue
Insiders · Profile

Curran Terrie

Director at Arcutis Biotherapeutics · President and Chief Executive at Phathom Pharmaceuticals. Filing since 22 Mar 2021. CIK 0001690298

ARQT Arcutis Biotherapeutics, Inc. Director · 3 trades PHAT Phathom Pharmaceuticals, Inc. President and Chief Executive · 9 trades
Company
Date
Role
Action
Shares
Amount
Of holding
ARQT Arcutis Biotherapeutics, Inc.
27 Aug 2026
Director
Sold at will
38,200
$956.12K
61.9%
ARQT Arcutis Biotherapeutics, Inc.
20 Aug 2026
Director
Sold at will
1,072
$27.91K
4.4%
PHAT Phathom Pharmaceuticals, Inc.
21 Jan 2025
President and Chief Executive
Sold at will
19,109
$125.88K
5.0%
ARQT Arcutis Biotherapeutics, Inc.
11 Nov 2024
Director
Sold at will
8,687
$94.24K
46.1%
PHAT Phathom Pharmaceuticals, Inc.
15 Jul 2024
President and Chief Executive
Sold at will
33,848
$396.70K
8.2%
PHAT Phathom Pharmaceuticals, Inc.
22 Mar 2024
President and Chief Executive
Sold at will
16,851
$153.51K
3.9%
PHAT Phathom Pharmaceuticals, Inc.
6 Apr 2023
President and Chief Executive
Bought
12,919
$101.03K
7.4%
PHAT Phathom Pharmaceuticals, Inc.
1 Mar 2023
President and Chief Executive
Sold, plan not stated
1,436
$12.27K
0.8%
PHAT Phathom Pharmaceuticals, Inc.
20 Jan 2023
President and Chief Executive
Sold, plan not stated
5,821
$47.73K
3.2%
PHAT Phathom Pharmaceuticals, Inc.
21 Nov 2022
President and Chief Executive
Sold, plan not stated
1,526
$14.65K
1.8%
PHAT Phathom Pharmaceuticals, Inc.
13 May 2022
President and Chief Executive
Bought
20,500
$151.84K
46.5%
PHAT Phathom Pharmaceuticals, Inc.
22 Mar 2021
President and Chief Executive
Sold, plan not stated
11,513
$498.75K
100%
12 decisions on file.